Simone M. Goldinger
The University of Queensland(AU)University of Zurich(CH)University Hospital of Zurich(CH)Melanoma Institute Australia(AU)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Cutaneous Melanoma Detection and Management, Immunotherapy and Immune Responses
Most-Cited Works
- → Genomic correlates of response to CTLA-4 blockade in metastatic melanoma(2015)2,936 cited
- → Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial(2015)1,554 cited
- → Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma(2019)1,066 cited
- → The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma(2013)931 cited
- → Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy(2016)638 cited
- → Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy(2016)556 cited